Skip to main content

Table 4 Association between clinicopathologic characteristics and HCC patient DFI through univariate and multivariate analysis with Cox regression survival model

From: Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data

Characteristics

Univariate analysis

Multivariate analysis

HR

95%CI

P-value

HR

95%CI

P-value

CDK6 (high vs. low)

0.7

0.4–1.1

0.147

0.7

0.4–1.3

0.310

RB1 expression (high vs. low)

0.7

0.4–1.2

0.213

1.1

0.6–2.1

0.656

Age (>40 vs. ≤ 40)

0.6

0.3–1.2

0.167

0.9

0.4–1.9

0.748

Gender (male vs. female)

1.0

0.6–1.6

0.862

   

Alcohol consumption (yes vs. no)

1.0

0.6–1.9

0.915

   

Histologic grade (G3–4 vs. G1–2)

1.4

1.0–1.9

0.083

1.3

0.9–1.8

0.228

M (M1 vs. M0)

5.5

0.7–40.4

0.722

   

N (N1 vs. N0)

3.9

0.5–28.6

0.180

1.1

0.0–119.9

0.953

T (T3–4 vs. T1–2)

1.6

1.2–2.1

0.001

0.8

0.1–5.9

0.800

Clinical stage (III-IV vs. I-II)

1.7

1.3–2.3

0.000

2.5

0.3–21.2

0.389

Postoperative ablation embolization (yes vs. no)

3.1

1.6–6.0

0.001

4.3

2.0–9.4

0.000

Radiation therapy (yes vs. no)

1.5

0.2–10.9

0.690

   

Vascular invasion (yes vs. no)

1.2

0.7–2.1

0.524

   

Family history of cancer (yes vs. no)

1.2

0.7–2.0

0.513

   

E2F2 (high vs. low)

2.2

1.3–3.7

0.004

2.0

1.1–3.7

0.029

  1. DFI Disease-free interval, T = topography distribution, N = lymph node metastasis, M = distant metastasis, CI Confidence interval